Pacira Pharmaceuticals buy Barclays PLC
Start price
23.10.23
/
50%
€26.20
Target price
23.10.24
€53.51
Performance (%)
-38.93%
End price
24.10.24
€16.00
Summary
This prediction ended on 24.10.24 with a price of €16.00. Massive losses of -38.93% were the result for the BUY prediction by Barclays_PLC. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 4.737% | 4.737% | -7.870% |
| iShares Core DAX® | -2,80 % | -1,40 % | -0,22 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % | 29,00 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % | 48,21 % |
| iShares S&P 500 | -3,41 % | 0,40 % | 20,28 % |
Comments by Barclays_PLC for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Barclays PLC from $60.00 to $57.00. They now have an "overweight" rating on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barclays_PLC for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
08.05.24
08.05.24
€35.35
08.05.25
08.05.25
-25.75%
09.05.25
09.05.25
